MicroRNAs correlating with outcome in patients treated with first-line bevacizumab for metastatic breast cancer

SP Gampenrieder; F Hamacher; G Rinnerthaler; Clemens Hufnagl; H Hackl; F Romeder; C Muss; C Hauser-Kronbeger; B Mlineritsch; Richard Greil

MicroRNAs correlating with outcome in patients treated with first-line bevacizumab for metastatic breast cancer

SP Gampenrieder, F Hamacher, G Rinnerthaler, Clemens Hufnagl, H Hackl, F Romeder, C Muss, C Hauser-Kronbeger, B Mlineritsch, Richard Greil

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center
Institute of Pathology

Research output: Contribution to journal › Abstract (Journal) › peer-review

1 Citation (Web of Science)

Original language	English
Journal	CANCER RESEARCH
Volume	75
Issue number	9
Publication status	Published - 2015
Event	37th Annual CTRC-AACR San Antonio Breast Cancer Symposium - San Antonio, TX Duration: 9 Dec 2014 → 13 Dec 2014

Cite this

Gampenrieder, SP., Hamacher, F., Rinnerthaler, G., Hufnagl, C., Hackl, H., Romeder, F., Muss, C., Hauser-Kronbeger, C., Mlineritsch, B., & Greil, R. (2015). MicroRNAs correlating with outcome in patients treated with first-line bevacizumab for metastatic breast cancer. CANCER RESEARCH , 75(9).

Gampenrieder, SP ; Hamacher, F ; Rinnerthaler, G et al. / MicroRNAs correlating with outcome in patients treated with first-line bevacizumab for metastatic breast cancer. In: CANCER RESEARCH 2015 ; Vol. 75, No. 9.

@article{7f28ce4bac764052b4ed8aeaf7999c69,

title = "MicroRNAs correlating with outcome in patients treated with first-line bevacizumab for metastatic breast cancer",

author = "SP Gampenrieder and F Hamacher and G Rinnerthaler and Clemens Hufnagl and H Hackl and F Romeder and C Muss and C Hauser-Kronbeger and B Mlineritsch and Richard Greil",

year = "2015",

language = "English",

volume = "75",

journal = "CANCER RESEARCH ",

issn = "0008-5472",

publisher = "Amer Assoc Cancer Research",

number = "9",

note = "37th Annual CTRC-AACR San Antonio Breast Cancer Symposium ; Conference date: 09-12-2014 Through 13-12-2014",

}

Gampenrieder, SP, Hamacher, F, Rinnerthaler, G, Hufnagl, C, Hackl, H, Romeder, F, Muss, C, Hauser-Kronbeger, C, Mlineritsch, B & Greil, R 2015, 'MicroRNAs correlating with outcome in patients treated with first-line bevacizumab for metastatic breast cancer', CANCER RESEARCH , vol. 75, no. 9.

MicroRNAs correlating with outcome in patients treated with first-line bevacizumab for metastatic breast cancer. / Gampenrieder, SP; Hamacher, F; Rinnerthaler, G et al.
In: CANCER RESEARCH , Vol. 75, No. 9, 2015.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - MicroRNAs correlating with outcome in patients treated with first-line bevacizumab for metastatic breast cancer

AU - Gampenrieder, SP

AU - Hamacher, F

AU - Rinnerthaler, G

AU - Hufnagl, Clemens

AU - Hackl, H

AU - Romeder, F

AU - Muss, C

AU - Hauser-Kronbeger, C

AU - Mlineritsch, B

AU - Greil, Richard

PY - 2015

Y1 - 2015

M3 - Abstract (Journal)

SN - 0008-5472

VL - 75

JO - CANCER RESEARCH

JF - CANCER RESEARCH

IS - 9

T2 - 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium

Y2 - 9 December 2014 through 13 December 2014

ER -

Gampenrieder SP, Hamacher F, Rinnerthaler G, Hufnagl C, Hackl H, Romeder F et al. MicroRNAs correlating with outcome in patients treated with first-line bevacizumab for metastatic breast cancer. CANCER RESEARCH . 2015;75(9).